Patents by Inventor Stephen E. Schneider

Stephen E. Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180044365
    Abstract: Processes and intermediates for preparing fluoroketolide compounds are described herein.
    Type: Application
    Filed: March 5, 2016
    Publication date: February 15, 2018
    Inventors: David Eugene PEREIRA, Stephen E. SCHNEIDER, Keshav DEO
  • Publication number: 20180016226
    Abstract: Neat 4-azidobutylamine and sails of 4-azidobutylamine and processes for producing the same are described herein. Amines represent a large class of organic compounds containing a basic nitrogen atom having a lone pair of electrons and one or more substituent groups. Many amines are used as precursors and feedstocks in a wide variety of industries such as textiles, agriculture, plastics, and pharmaceuticals. One such amine is 4-azidobutylamine, N3-(CH2)4NH2, an amine of butane that also includes an azide.
    Type: Application
    Filed: February 5, 2016
    Publication date: January 18, 2018
    Inventors: Stephen E. SCHNEIDER, David Eugene PEREIRA
  • Publication number: 20120040891
    Abstract: Provided is an HIV fusion inhibitor peptide having an amino acid sequence of any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:15; and provided is a pharmaceutical composition comprising a HIV fusion inhibitor peptide and one or more of a pharmaceutically acceptable carrier and macromolecular carrier, and uses and methods of treatment provided by these compositions.
    Type: Application
    Filed: August 31, 2011
    Publication date: February 16, 2012
    Inventors: John J. Dwyer, Brian L. Bray, Stephen E. Schneider, Huyi Zhang, Nicolai A. Tvermoes, Barbara E. Johnston, Paul E. Friedrich
  • Patent number: 8034899
    Abstract: Provided is an HIV fusion inhibitor peptide having an amino acid sequence of any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:15; and provided is a pharmaceutical composition comprising a HIV fusion inhibitor peptide and one or more of a pharmaceutically acceptable carrier and macromolecular carrier, and uses and methods of treatment provided by these compositions.
    Type: Grant
    Filed: October 20, 2008
    Date of Patent: October 11, 2011
    Assignee: Trimeris, Inc.
    Inventors: John Dwyer, Brian L. Bray, Stephen E. Schneider, Huyi Zhang, Nicolai A. Tvermoes, Barbara E. Johnston, Paul E. Friedrich
  • Publication number: 20100261876
    Abstract: Provided herein are methods for synthesis of peptides. In particular, provided herein are methods of synthesis for therapeutic antiviral peptides.
    Type: Application
    Filed: September 25, 2008
    Publication date: October 14, 2010
    Inventors: Brian L. Bray, Barbara E. Johnston, Stephen E. Schneider, Nicolai A. Tvermoes, Huyi Zhang, Paul E. Friedrich
  • Publication number: 20090105143
    Abstract: Provided is an HIV fusion inhibitor peptide having an amino acid sequence of any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:15; and provided is a pharmaceutical composition comprising a HIV fusion inhibitor peptide and one or more of a pharmaceutically acceptable carrier and macromolecular carrier, and uses and methods of treatment provided by these compositions.
    Type: Application
    Filed: October 20, 2008
    Publication date: April 23, 2009
    Inventors: John J. Dwyer, Brian L. Bray, Stephen E. Schneider, Huyi Zhang, Nicolai A. Tvermoes, Barbara E. Johnston, Paul E. Friedrich
  • Patent number: 7456251
    Abstract: Provided is an HIV fusion inhibitor peptide having an amino acid sequence of any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, or SEQ ID NO:15; and provided is a pharmaceutical composition comprising a HIV fusion inhibitor peptide and one or more of a pharmaceutically acceptable carrier and macromolecular carrier, and uses and methods of treatment provided by these compositions.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: November 25, 2008
    Assignee: Trimeris, Inc.
    Inventors: John Dwyer, Brian L. Bray, Stephen E. Schneider, Huyi Zhang, Nikolai A. Tvermores, Barbara E. Johnston, Paul E. Friedrich
  • Patent number: 5211593
    Abstract: A system is disclosed for applying a graphics-imprinted skin to a substrate of expanded polyolefin foam. The system is used to create bodyboards and other foam devices with durable graphic images. The skin is made of a plurality of thin-film polyethylene layers adhesively bonded together. The outermost layer is a sheet of nonopaque (i.e., clear) polyethylene with graphic images imprinted on one side. The images are printed in reverse pattern and viewed through the polyethylene sheet from the other side. The nonopaque sheet is then adhesively bonded to an opaque backing sheet along the graphic-imprinted surface. The result is a flexible laminated skin material with visible graphics on one side. The skin material is then thermolaminated to the foam substrate with the graphics facing outwardly. A method of continuous fabrication is also disclosed.
    Type: Grant
    Filed: January 23, 1992
    Date of Patent: May 18, 1993
    Assignee: Kransco
    Inventors: Stephen E. Schneider, Steven M. Moran
  • Patent number: 4805546
    Abstract: A generally trapezoidal fin (22) is pivotally fastened to a casing which can receive the entire fin, permitting total retraction of the fin. The casing is formed with at least one notch (42) for selectively positioning the fin relative to the casing. In a preferred embodiment, the fin is operated by a lever member (26) which has a knob (50) at its distal end for use in positioning the fin (22) from above.
    Type: Grant
    Filed: February 1, 1988
    Date of Patent: February 21, 1989
    Assignee: Kransco Manufacturing, Inc.
    Inventors: Douglas A. Geller, Stephen E. Schneider, William C. Holbrook
  • Patent number: 4662852
    Abstract: A floating, reclining lounge (10) including a mechanism to permit it to be easily adjusted in the aquatic environment without the need for manually applied lifting force. In one embodiment, the mechanism includes a slotted bracket (30) with resilient sockets which enable the seat of the lounge to be moved and secured in select positions of adjustment. In another embodiment, the mechanism include a slotted bracket (100) having a rack (110) and pinion (108) to facilitate such adjustment.
    Type: Grant
    Filed: January 24, 1986
    Date of Patent: May 5, 1987
    Assignee: Kransco Manufacturing, Inc.
    Inventors: Stephen E. Schneider, Douglas A. Geller, Richard E. Morrison
  • Patent number: 4115492
    Abstract: Normally hydrophobic, polyethylene hollow fibers having contiguous microporosity are prepared by extruding a heated solution of a polyethylene and an ester from a hollow fiber spinnerette, simultaneously cooling and drawing the forming fibers to a ratio of up to 40 to 1, drawing the gelled fibers to an overall ratio of from about 1.5/1 to 800/1 and then removing the ester. The maximum pore radius ranges up to about 50A, and the fibers have gas permeabilities approaching 10.sup.-2 cc (STP) per cm.sup.2 per second per cm. Hg. transmembrane pressure differential. A significant increase in permeability over polyethylene hollow fibers made according to the teachings of the prior art is achieved.
    Type: Grant
    Filed: January 28, 1977
    Date of Patent: September 19, 1978
    Assignee: The Dow Chemical Company
    Inventors: Robert D. Mahoney, Stephen E. Schneider
  • Patent number: 4020230
    Abstract: Normally hydrophobic, polyethylene hollow fibers having contiguous microporosity are prepared by extruding a heated solution of a polyethylene and an ester from a hollow fiber spinnerette, simultaneously cooling and drawing the forming fibers to a ratio of up to 40 to 1, drawing the gelled fibers to an overall ratio of from about 1.5/1 to 800/1 and then removing the ester. The maximum pore radius ranges up to about 50A, and the fibers have gas permeabilities approaching 10.sup.-.sup.2 cc (STP) per cm.sup.2 per second per cm. Hg. transmembrane pressure differential. A significant increase in permeability over polyethylene hollow fibers made according to the teachings of the prior art is achieved.
    Type: Grant
    Filed: October 3, 1975
    Date of Patent: April 26, 1977
    Assignee: The Dow Chemical Company
    Inventors: Robert D. Mahoney, Stephen E. Schneider